E/e'Biomarker2 papersHuman trial1Animals1LatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 2Oct 2026: 02British Journal of PharmacologyAnimals·11 SepGPER stimulation attenuates mitochondrial dysfunction and cardiac dysfunction in ovariectomized mice with heart failure with preserved ejection fraction (HFpEF)Heart failure with preserved ejection fractionClinical Journal of the American Society of NephrologyHuman trial·3 SepEffects and Safety of Henagliflozin on Cardiac Structure in Dialysis Patients with Heart Failure with Preserved Ejection FractionHeart failure with preserved ejection fraction
British Journal of PharmacologyAnimals·11 SepGPER stimulation attenuates mitochondrial dysfunction and cardiac dysfunction in ovariectomized mice with heart failure with preserved ejection fraction (HFpEF)Heart failure with preserved ejection fraction
Clinical Journal of the American Society of NephrologyHuman trial·3 SepEffects and Safety of Henagliflozin on Cardiac Structure in Dialysis Patients with Heart Failure with Preserved Ejection FractionHeart failure with preserved ejection fraction